EdgeMarketInstruments › CERS

CERS — CERUS CORP

US Healthcare Medical devices equity mkt cap 562.3M
2.81 +0.72% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 1.18 · high 3.28

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day+0.72%
1 week-5.70%
1 month-2.09%
3 months+2.55%
6 months+16.60%
Year to date+42.64%
1 year+142.24%
3 years+56.11%
5 years-53.24%

Technicals

RSI 1477.0
vs 50-day avg-0.17%
vs 200-day avg+21.46%
Volatility 1y79.5%
Max drawdown 1y-38.32%
Avg volume 30d2.8M
Daily bars held2,674
History from2016-01-04

Measured signals that fired on CERS

datesignal measured base rate
2026-07-31Short volume far above its own normal
short
-0.76% over 21 days · t = -2.79 · n = 5,897
statistically distinguishable from its control group
2026-05-27Breakout to a 52-week high
price
-1.00% over 21 days · t = -8.58 · n = 24,386
statistically distinguishable from its control group
2026-03-11Short volume far above its own normal
short
-0.76% over 21 days · t = -2.79 · n = 5,897
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-08-17Jensen Chrystal
Chief Legal Officer
Open-market sale 10b5-1 plan30.0K2.9889.5K
2026-07-16Jayaraman Vivek K
Chief Executive Officer
Open-market sale 10b5-1 plan16.7K3.1652.7K
2026-07-01Jayaraman Vivek K
Chief Operating Officer
Grant or award 10b5-1 plan554.5K0.000
2026-06-30Greenman William Mariner
President and CEO
Open-market sale 10b5-1 plan101.9K2.94299.9K
2026-06-30Jayaraman Vivek K
Chief Operating Officer
Open-market sale 10b5-1 plan42.4K2.94124.7K
2026-06-30Green Kevin Dennis
Chief Financial Officer
Open-market sale 10b5-1 plan33.7K2.9499.1K
2026-06-30Jensen Chrystal
Chief Legal Officer
Open-market sale 10b5-1 plan24.3K2.9471.6K
2026-06-30Jensen Chrystal
Chief Legal Officer
Grant or award 10b5-1 plan55.0K0.000
2026-06-30Jayaraman Vivek K
Chief Operating Officer
Grant or award 10b5-1 plan80.0K0.000
2026-06-30Green Kevin Dennis
Chief Financial Officer
Grant or award 10b5-1 plan63.6K0.000

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
BlackRock, Inc.39.3M21.6M
ARK Investment Management LLC34.9M19.2M
Soleus Capital Management, L.P.19.6M10.8M
BAKER BROS. ADVISORS LP18.2M10.0M
VANGUARD CAPITAL MANAGEMENT LLC14.8M8.1M
WASATCH ADVISORS LP9.6M5.3M
GEODE CAPITAL MANAGEMENT, LLC8.4M4.6M
Sumitomo Mitsui Trust Group, Inc.8.2M4.5M
Amova Asset Management Americas, Inc.8.2M4.5M
SILVERCREST ASSET MANAGEMENT GROUP LLC7.7M4.2M

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d47.0% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about CERS

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open CERS in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →